AI Drug Discovery
AI Drug Discovery Software Solutions
axinite labs builds AI drug discovery software for pharma and life science teams in the USA and India — computational drug discovery platforms, analytical drug discovery solutions, and pharma analytics software that shorten the path from lab data to insight.
Solutions
From lab data to insight, faster
AI, computational, and analytical drug discovery platforms built for research teams.
AI Drug Discovery Platforms
AI drug discovery software that applies machine learning to screening data, compound properties, and literature — surfacing candidates faster.
Computational Drug Discovery
Computational drug discovery software — molecular data pipelines, property prediction, and simulation workflows engineered for scale.
Analytical Drug Discovery
Analytical drug discovery solutions that turn instrument output into clean, queryable datasets with automated QC along the way.
Pharma Analytics Software
Pharma analytics software for research and commercial teams — dashboards and reporting across trials, screening, and portfolio data.
Life Science Data Engineering
Life science software solutions — LIMS integrations, research data lakes, and pipelines that connect instruments, ELNs, and analysis tools.
Research Dashboards & Collaboration
Scientist-friendly dashboards and search across experiments, so insights are shared instead of trapped in individual notebooks.
FAQ
Frequently asked questions
Do you provide drug discovery software in the USA and India?
Yes. We build and support AI drug discovery software for research teams across the USA and India, with delivery teams in Canada and Australia providing 24/7 coverage.
Can you integrate with our lab instruments and LIMS?
Yes. We build pipelines that ingest data from instruments, LIMS, and electronic lab notebooks into a unified research data platform your scientists can query directly.
Is the software validation-friendly for regulated environments?
Yes. We design with audit trails, role-based access, and documentation aligned to GxP and 21 CFR Part 11 expectations, so validation is straightforward.